Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kneshay N. Harper"'
Autor:
Chih Jian Lih, P. Mickey Williams, Jonathan C. Yau, Vivekananda Datta, Keyur P. Patel, Eric C. Polley, Kneshay N. Harper, James H. Doroshow, Long P. Le, Jeffrey Sklar, Savitri Krishnamurthy, Amelia Raymond, Rajesh R. Singh, Zenta Walther, Karin E. Finberg, Sandra Canosa, Rajyalakshmi Luthra, Karyn Ronski, Hayley Robinson, A. John Iafrate, Stanley R. Hamilton, David J. Sims, Geeta S. Mantha, Lisa M. McShane, Mark J. Routbort, Barbara A. Conley, Courtney H. Bouk, Robin D. Harrington
Publikováno v:
The Journal of Molecular Diagnostics. 19:313-327
The National Cancer Institute–Molecular Analysis for Therapy Choice (NCI-MATCH) trial is a national signal-finding precision medicine study that relies on genomic assays to screen and enroll patients with relapsed or refractory cancer after standar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b936869a4d9c4adfd66651b0dcf2f868
https://doi.org/10.1016/j.jmoldx.2016.10.007
https://doi.org/10.1016/j.jmoldx.2016.10.007
Autor:
Paul M. Williams, James H. Doroshow, Robin D. Harrington, Larry Rubinstein, Yingdong Zhao, William D. Walsh, Michele G. Mehaffey, David J. Sims, Barbara A. Conley, Thomas Forbes, Courtney H. Bouk, Vivekananda Datta, Biswajit Das, Alice P. Chen, Richard M. Simon, Shivaani Kummar, Kneshay N. Harper, Chih Jian Lih, Eric C. Polley
Publikováno v:
The Journal of Molecular Diagnostics. 18:51-67
Robust and analytically validated assays are essential for clinical studies. We outline an analytical validation study of a targeted next-generation sequencing mutation-detection assay used for patient selection in the National Cancer Institute Molec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::721e3e4d31f9693c5573549632ebf4ad
https://doi.org/10.1016/j.jmoldx.2015.07.006
https://doi.org/10.1016/j.jmoldx.2015.07.006
Autor:
Cynthia Winter, Paul M. Williams, Peter J. O'Dwyer, Linda Zane, Gregory J. Tsongalis, A. John Iafrate, Keith T. Flaherty, Chris Karlovich, Jennifer Lee, Ting-Chia Chang, Stanley R. Hamilton, Alice P. Chen, Laura M. Yee, Barbara A. Conley, Kneshay N. Harper, Jeffrey Sklar, Lyndsay Harris, Robin D. Harrington, James V. Tricoli, David Patton
Publikováno v:
Journal of Clinical Oncology. 37:3016-3016
3016 Background: NCI-MATCH is a precision medicine trial that assigns treatment to refractory cancer patients by tumor mutation profile rather than by histology. After screening fresh tumor biopsies from nearly 6000 patients many treatment arms did n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a0c7680c2d98566462b940552e35c01
https://doi.org/10.1200/jco.2019.37.15_suppl.3016
https://doi.org/10.1200/jco.2019.37.15_suppl.3016
Autor:
Chih-Jian, Lih, Robin D, Harrington, David J, Sims, Kneshay N, Harper, Courtney H, Bouk, Vivekananda, Datta, Jonathan, Yau, Rajesh R, Singh, Mark J, Routbort, Rajyalakshmi, Luthra, Keyur P, Patel, Geeta S, Mantha, Savitri, Krishnamurthy, Karyn, Ronski, Zenta, Walther, Karin E, Finberg, Sandra, Canosa, Hayley, Robinson, Amelia, Raymond, Long P, Le, Lisa M, McShane, Eric C, Polley, Barbara A, Conley, James H, Doroshow, A John, Iafrate, Jeffrey L, Sklar, Stanley R, Hamilton, P Mickey, Williams
Publikováno v:
The Journal of molecular diagnostics : JMD. 19(2)
The National Cancer Institute-Molecular Analysis for Therapy Choice (NCI-MATCH) trial is a national signal-finding precision medicine study that relies on genomic assays to screen and enroll patients with relapsed or refractory cancer after standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57b5478acf225527f9fc0716dc7f77b3
https://pubmed.ncbi.nlm.nih.gov/28130021
https://pubmed.ncbi.nlm.nih.gov/28130021
Autor:
David J. Sims, Corinne Camalier, P. Mickey Williams, Kneshay N. Harper, Barbara A. Conley, James H. Doroshow, Paul M. McGregor, Biswajit Das, Courtney H. Bouk, Robin D. Harrington, Thomas Forbes, Chih Jian Lih, Eric C. Polley, Michele G. Mehaffey
Although next-generation sequencing technologies have been widely adapted for clinical diagnostic applications, an urgent need exists for multianalyte calibrator materials and controls to evaluate the performance of these assays. Control materials wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0e8fc30838f960e73cd330347249022
https://europepmc.org/articles/PMC4851732/
https://europepmc.org/articles/PMC4851732/
Autor:
David J. Sims, Hua-Jun He, Steve Choquette, Kenneth D. Cole, Kneshay N. Harper, Andrew Y. Kayserian, Steve Lund, Jamie L. Almeida, Chih-Jian Lih, Han Si, Paul M. McGregor, P. Mickey Williams, Biswajit Das, Corinne Camalier, Robin D. Harrington
Publikováno v:
The Journal of Molecular Diagnostics. (5):753-761
The National Institute of Standards and Technology (NIST) Standard Reference Materials 2373 is a set of genomic DNA samples prepared from five breast cancer cell lines with certified values for the ratio of the HER2 gene copy number to the copy numbe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::308058bd69a75ce6a642c31643dc6153